LEU supplementation delayed tumor growth (figure 6F), but not enhanced tumor progression (online supplemental figure S4D), while the Rragd−/− OTI CD8+ T cells did not response to LEU-supplement (online supplemental figure S4E). Here, CD8A is linked to neoplasm.